Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Single Blind Study of the Clinical Efficacy and Safety of GNR-060 (JSC "GENERIUM", Russia) Compared to Metalyse (Boehringer Ingelheim Pharma GmbH & Co.KG, Germany) in Patients With ST Elevation Myocardial Infarction

NCT05601999 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.

NCT NCT05601999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Single Blind Study of the Clinical Efficacy and Safety of GNR-060 (JSC "GENERIUM", Russia) Compared to Metalyse (Boehringer Ingelheim Pharma GmbH & Co.KG, Germany) in Patients With ST Elevation Myocardial Infarction
Lead sponsor
AO GENERIUM
Phase
Phase 3
Overall status
Completed
Start date
September 3, 2021
Completion date
January 15, 2025
Enrollment
244 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

st elevation myocardial infarction